Difference between revisions of "Paclitaxel, nanoparticle albumin-bound (Abraxane)"
m |
m |
||
| Line 1: | Line 1: | ||
| − | Also known as nab-paclitaxel. | + | Also known as ab-pac, albumin-bound paclitaxel, or nab-paclitaxel. |
==General information== | ==General information== | ||
Revision as of 20:58, 1 March 2012
Also known as ab-pac, albumin-bound paclitaxel, or nab-paclitaxel.
General information
Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization. Paclitaxel interferes with the normal dynamic reorganization of microtubules that is necessary for regular interphase/mitosis processes. It also leads to creation of abnormal bundles of microtubules. The nanoparticle albumin bound characteristic of Abraxane eliminates the need for it to be dissolved in Cremophor EL (polyoxyethylated castor oil) like Paclitaxel (Taxol) and the risk of hypersensitivity infusion reactions related to Cremophor.[1][2]
Route: IV
Extravasation: irritant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Patient drug information
- Paclitaxel, albumin-bound (Abraxane) package insert PDF pages 12-13[1]
- Paclitaxel, nanoparticle albumin-bound (Abraxane) patient drug information (UpToDate)[3]